Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

2020 European Heart Journal 1,363 citations

Abstract

Abstract

Keywords

MedicineConsensus conferenceAtherosclerotic cardiovascular diseaseDiseaseStatement (logic)PathophysiologyBioinformaticsPathologyInternal medicineLaw

Affiliated Institutions

Related Publications

The changing landscape of atherosclerosis

Emerging evidence has spurred a considerable evolution of concepts relating to atherosclerosis, and has called into question many previous notions. Here I review this evidence, ...

2021 Nature 2293 citations

Atherosclerosis — An Inflammatory Disease

Atherosclerosis is an inflammatory disease. Because high plasma concentrations of cholesterol, in particular those of low-density lipoprotein (LDL) cholesterol, are one of the p...

1999 New England Journal of Medicine 21530 citations

Atherosclerosis

Atherosclerosis, the formation of fibrofatty lesions in the artery wall, causes much morbidity and mortality worldwide, including most myocardial infarctions and many strokes, a...

2019 Nature Reviews Disease Primers 2698 citations

Publication Info

Year
2020
Type
article
Volume
41
Issue
24
Pages
2313-2330
Citations
1363
Access
Closed

External Links

Citation Metrics

1363
OpenAlex

Cite This

Jan Borén, M. John Chapman, Ronald M. Krauss et al. (2020). Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal , 41 (24) , 2313-2330. https://doi.org/10.1093/eurheartj/ehz962

Identifiers

DOI
10.1093/eurheartj/ehz962